INCARDA THERAPEUTICS
InCarda Therapeutics is a clinical-stage drug delivery company pioneering a novel approach of treating acute cardiovascular diseases/conditions by the inhalation route. Lead product is InRhythm, an inhaled formulation of an antiarrhythmic drug to treat acute paroxysmal atrial fibrillation events within minutes at home, at work, or anywhere. Completed Phase 1 and currently advancing lead product through Phase 2. InCarda Therapeutics was founded in Newark, California.
INCARDA THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2009-01-01
Address:
Newark, California, United States
Country:
United States
Website Url:
http://www.incardatherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+1 510 422 5522
Email Addresses:
[email protected]
Total Funding:
77.88 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Morningside Venture Investments
Morningside Venture Investments investment in Series C - InCarda Therapeutics
HealthCap
HealthCap investment in Series C - InCarda Therapeutics
Innoviva
Innoviva investment in Series C - InCarda Therapeutics
Deerfield
Deerfield investment in Series C - InCarda Therapeutics
Asset Management Ventures (AMV)
Asset Management Ventures (AMV) investment in Series B - InCarda Therapeutics
Deerfield
Deerfield investment in Series B - InCarda Therapeutics
Morningside Ventures
Morningside Ventures investment in Series B - InCarda Therapeutics
HealthCap
HealthCap investment in Series B - InCarda Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Series B - InCarda Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Venture Round - InCarda Therapeutics
Official Site Inspections
http://www.incardatherapeutics.com
- Host name: 251.69.197.104.bc.googleusercontent.com
- IP address: 104.197.69.251
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "InCarda Therapeutics"
InCarda Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +1 510 422 5522 InCarda Therapeutics is a clinical-stage drug delivery company pioneering a novel approach of treating …See details»
InCarda Therapeutics | About InCarda
InCarda Therapeutics, Inc. is a privately-held, clinical-stage biopharmaceutical company pioneering a novel approach of treating cardiovascular conditions by the inhalation route.See details»
Incarda Therapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Incarda Therapeutics, Inc. of Newark, CA. Get the latest business insights from Dun & Bradstreet.See details»
Our Team - InCarda Therapeutics
InCarda is led by a seasoned team with highly complementary expertise. Myles D. Greenberg, MD, MBA. President & Chief Executive OfficerSee details»
Working At InCarda Therapeutics: Company Overview and Culture
Incardatherapeutics.com. Organization Type. Private. CEO. Grace E. Colón. Social Media. InCarda Therapeutics is a clinical stage drug delivery company pioneering a novel approach of …See details»
InCarda Therapeutics - Overview, News & Similar companies
Aug 25, 2022 InCarda Therapeutics contact info: Phone number: (510) 422-5522 Website: www.incardatherapeutics.com What does InCarda Therapeutics do? InCarda Therapeutics, …See details»
InCarda Therapeutics Company Overview, Contact Details
Oct 21, 2020 Jul 25, 2022 | incardatherapeutics.com. InCarda Therapeutics, Inc. hired Robert Lisicki as chief executive officer on Oct 3rd '22. Inhaled flecanide developer InCarda …See details»
InCarda Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Introduction: The INSTANT trial was a multicenter, open-label, single-arm study of flecainide acetate oral inhalation solution (FlecIH) for acute conversion of recent-onset, symptomatic …See details»
InCarda Therapeutics - LinkedIn
InCarda Therapeutics is a clinical stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route.See details»
Org Chart InCarda Therapeutics - The Official Board
The organizational chart of InCarda Therapeutics displays its 12 main executives including Myles Greenberg, Carol Manchester and Narsi RangachariSee details»
InCarda CEO Grace Colón Elected to the Board of the …
Jun 23, 2021 InCarda CEO Grace Colón Elected to the Board of the Biotechnology Innovation Organization (BIO) InCarda CEO Grace Colón was elected to the Board of the Biotechnology …See details»
InCarda Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for InCarda Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
InCarda’s Competitors, Revenue, Number of Employees, Funding
InCarda’s Profile, Revenue and Employees. InCarda is a California-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cardiovascular …See details»
InCarda Therapeutics - Craft
InCarda Therapeutics has 5 employees across 2 locations and $47.57 m in total funding,. See insights on InCarda Therapeutics including office locations, competitors, revenue, financials, …See details»
News & Updates - InCarda Therapeutics
Grace Colón recognized by the Biotechnology Innovation Organization as one of 25 Hispanic Trailblazers to Know in Science and Biotech ... Tweets by InCardaThera. For Media inquiries: …See details»
InCarda Therapeutics Announces Execution of Planned CEO …
Oct 4, 2022 Robert Lisicki Appointed as New Chief Executive Officer and Board Member; Possesses Broad Commercial and Public Company Experience Grace E, Colón, Ph.D., …See details»
InCarda raises $30M to reimagine afib treatment with drug-device …
Oct 21, 2020 InCarda aims to enter phase 3 trials in the first half of next year. The team will present findings from the phase 2 trial at the American Heart Association meeting this November.See details»
Investors - InCarda Therapeutics
HealthCap is a European venture capital firm investing exclusively and globally in life sciences. The investment strategy focuses on diseases with high unmet medical needs and …See details»
Pipeline Overview - InCarda Therapeutics
InCarda is actively developing therapies for significant unmet needs in cardiovascular medicine and related conditions. Our intellectual property and development expertise are being applied …See details»